Gilbert's Syndrome may decrease Very Low Density Lipoprotein

}

(BioMindmap Proof Quality is Very Light.)

Gilbert's Syndrome may decrease VLDL
(BioMindmap Proof Quality is Very Light.)

0.8 ValidityScore

Valid or Invalid? Login to vote or flag.

Proofs

2013

Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome.
Wallner M, et al.
Lower concentration of the VLDL (very-low-density
lipoprotein), IDL (intermediate-density lipoprotein) and LDL
sub-fractions, in addition to reduced TAG (triacylglycerol) concentration [18] and reduced total serum cholesterol [13] in GS
subjects are reported.
Comments: Lower concentration of the VLDL (very-low-density
lipoprotein), IDL (intermediate-density lipoprotein) and LDL
sub-fractions, in addition to reduced TAG (triacylglycerol) concentration [18] and reduced total serum cholesterol [13] in GS
subjects are reported.
#Adult, Aging, Animal, Animals, Bilirubin, Biomarkers, Cardiovascular Diseases, Case-Control Studies, Disease Models, Female, Gilbert Disease, Gunn, Humans, Inflammation, Lipoproteins, Male, Middle Aged, Rats, Rats, Young Adult
ncbi.nlm.nih.gov/pubmed/23566065
Read 10.1042/CS20120661

From this research we know that
2.5
Gilbert's Syndrome decreases Triglycerides
(BioMindmap Proof Quality is Acceptable.)
4.1
Gilbert's Syndrome may decrease BMI
1.5
Gilbert's Syndrome may prevent CVD
(BioMindmap Proof Quality is Low.)
1.5
Gilbert's Syndrome may lower Serum Amyloid A
(BioMindmap Proof Quality is Low.)
1.8
Gilbert's Syndrome reduces Apolipoprotein B
(BioMindmap Proof Quality is Low.)
2.5
Gilbert's Syndrome decreases Cholesterol
(BioMindmap Proof Quality is Acceptable.)
5.1
Gilbert's Syndrome decreases IL-6
7.0
Gilbert's Syndrome decreases LDL
+1
1.5
Gilbert's Syndrome may increase Bilirubin
(BioMindmap Proof Quality is Low.)
1.4
Gilbert's Syndrome reduces Apo-A1
(BioMindmap Proof Quality is Low.)
1.8
Gilbert's Syndrome reduces SAA
(BioMindmap Proof Quality is Low.)
1.5
Serum Amyloid A is marker of CVD
(BioMindmap Proof Quality is Low.)
1.5
Apo-B/Apo-A1 ratio is marker of CVD
(BioMindmap Proof Quality is Low.)
0.6
Gilbert's Syndrome may reduce IDL-3
(BioMindmap Proof Quality is Very Light.)
-2.4
Perhaps, Gilbert's Syndrome may reduce LDL-1
(BioMindmap Proof Quality is Negative.) (BioMindmap had flagged this statement.)
1.8
IL-6 induces CRP
(BioMindmap Proof Quality is Low.)
0.8
CRP may increase CVD
(BioMindmap Proof Quality is Very Light.)
0.6
CRP may increase Diabetes Type 2
(BioMindmap Proof Quality is Very Light.)
0.6
Gilbert's Syndrome may decrease IDL
(BioMindmap Proof Quality is Very Light.)
0.8
Gilbert's Syndrome may decrease VLDL
(BioMindmap Proof Quality is Very Light.)
0.6
Gilbert's Syndrome may decrease Apo-B/Apo-A1 ratio
(BioMindmap Proof Quality is Very Light.)

Add Biolink with same Proof

Add extra Proof

ranked

Gilbert's Syndrome may decrease VLDL (BioMindmap Proof Quality is Very Light.)

Proofs

Gilbert's Syndrome may decrease VLDL
(BioMindmap Proof Quality is Very Light.)